APP and Alzheimer disease: Compared with vehicle-treated APP/PS1 mice, FTS•B-treated AD mice exhibited less chaotic movements (Fig. 1a) and shorter escape latencies (p < 0.05; Fig. 1b), and crossed the platform more times (p < 0.05; Fig. 1c).